These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
852 related items for PubMed ID: 10975816
1. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. Traidl C, Sebastiani S, Albanesi C, Merk HF, Puddu P, Girolomoni G, Cavani A. J Immunol; 2000 Sep 15; 165(6):3058-64. PubMed ID: 10975816 [Abstract] [Full Text] [Related]
2. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells. Yanai F, Ishii E, Kojima K, Hasegawa A, Azuma T, Hirose S, Suga N, Mitsudome A, Zaitsu M, Ishida Y, Shirakata Y, Sayama K, Hashimoto K, Yasukawa M. J Immunol; 2003 Feb 15; 170(4):2205-13. PubMed ID: 12574394 [Abstract] [Full Text] [Related]
3. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures. Frost PJ, Butterfield LH, Dissette VB, Economou JS, Bonavida B. J Immunol; 2001 Mar 01; 166(5):3564-73. PubMed ID: 11207317 [Abstract] [Full Text] [Related]
4. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. Yasukawa M, Ohminami H, Arai J, Kasahara Y, Ishida Y, Fujita S. Blood; 2000 Apr 01; 95(7):2352-5. PubMed ID: 10733506 [Abstract] [Full Text] [Related]
5. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. Albanesi C, Cavani A, Girolomoni G. J Immunol; 1999 Jan 01; 162(1):494-502. PubMed ID: 9886425 [Abstract] [Full Text] [Related]
6. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements. Tsujimura K, Takahashi T, Iwase S, Matsudaira Y, Kaneko Y, Yagita H, Obata Y. J Immunol; 1998 Jun 01; 160(11):5253-61. PubMed ID: 9605121 [Abstract] [Full Text] [Related]
7. Porcine endothelial cells, unlike human endothelial cells, can be killed by human CTL via Fas ligand and cannot be protected by Bcl-2. Zheng L, Ben LH, Pober JS, Bothwell AL. J Immunol; 2002 Dec 15; 169(12):6850-5. PubMed ID: 12471117 [Abstract] [Full Text] [Related]
8. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways. Yang S, Haluska FG. J Immunol; 2004 Apr 01; 172(7):4599-608. PubMed ID: 15034078 [Abstract] [Full Text] [Related]
9. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction. Schnyder B, Frutig K, Mauri-Hellweg D, Limat A, Yawalkar N, Pichler WJ. Clin Exp Allergy; 1998 Nov 01; 28(11):1412-7. PubMed ID: 9824415 [Abstract] [Full Text] [Related]
10. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, Horand F, Hahne M, Kägi D, Kaiserlian D, Nicolas JF. J Exp Med; 1999 Mar 01; 189(5):779-86. PubMed ID: 10049941 [Abstract] [Full Text] [Related]
11. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo. Aung S, Graham BS. J Immunol; 2000 Apr 01; 164(7):3487-93. PubMed ID: 10725701 [Abstract] [Full Text] [Related]
12. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity. Kuwano K, Akashi A, Arai S. Cell Immunol; 1998 May 01; 185(2):114-22. PubMed ID: 9636689 [Abstract] [Full Text] [Related]
13. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Vukmanovic-Stejic M, Vyas B, Gorak-Stolinska P, Noble A, Kemeny DM. Blood; 2000 Jan 01; 95(1):231-40. PubMed ID: 10607707 [Abstract] [Full Text] [Related]
14. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways. Benihoud K, Bonardelle D, Bobé P, Kiger N. Eur J Immunol; 1997 Feb 01; 27(2):415-20. PubMed ID: 9045912 [Abstract] [Full Text] [Related]
15. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses. Dobrzanski MJ, Reome JB, Hollenbaugh JA, Dutton RW. J Immunol; 2004 Feb 01; 172(3):1380-90. PubMed ID: 14734713 [Abstract] [Full Text] [Related]
16. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity. Mitsui T, Miyake Y, Kakeya H, Osada H, Kataoka T. J Immunol; 2004 Mar 15; 172(6):3428-36. PubMed ID: 15004142 [Abstract] [Full Text] [Related]
17. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes. Sandberg JK, Fast NM, Nixon DF. J Immunol; 2001 Jul 01; 167(1):181-7. PubMed ID: 11418647 [Abstract] [Full Text] [Related]
18. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin. Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ. J Immunol; 2002 Apr 01; 168(7):3484-92. PubMed ID: 11907109 [Abstract] [Full Text] [Related]
19. Differential contribution of Fas- and perforin-mediated mechanisms to the cell-mediated cytotoxic activity of naive and in vivo-primed intestinal intraepithelial lymphocytes. Corazza N, Müller S, Brunner T, Kägi D, Mueller C. J Immunol; 2000 Jan 01; 164(1):398-403. PubMed ID: 10605035 [Abstract] [Full Text] [Related]
20. Antigen-dependent release of IFN-gamma by cytotoxic T cells up-regulates Fas on target cells and facilitates exocytosis-independent specific target cell lysis. Müllbacher A, Lobigs M, Hla RT, Tran T, Stehle T, Simon MM. J Immunol; 2002 Jul 01; 169(1):145-50. PubMed ID: 12077239 [Abstract] [Full Text] [Related] Page: [Next] [New Search]